Başkan Bedriye Mermerci, Sivas Filiz, Alemdaroğlu Ebru, Duran Semra, Ozoran Kürşat
Clinic of Physical Medicine and Rehabilitation, Ankara Numune Education and Research Hospital, Ankara, Turkey.
Rheumatol Int. 2007 Apr;27(6):579-84. doi: 10.1007/s00296-007-0323-8. Epub 2007 Feb 8.
The aim of this study was to investigate the association of vertebral deformities developed as a result of osteoporosis in female patients with rheumatoid arthritis (RA) with bone mineral density (BMD) and disease activity parameters. In the study, 100 female patients with the diagnosis of RA and 56 healthy subjects were recruited. Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and rheumatoid factor (RF) tests were performed and the number of swollen and tender joints, level of pain and health assessment questionnaire (HAQ) were recorded in order to evaluate disease activity. Anteroposterior and lateral thoracic and lumbosacral roentgenograms of all patients were taken for radiological examination and deformities of vertebrae were assessed. BMD measurements of patients were performed on vertebrae L1-4 of lumbar region and on total hip, femur neck, trochanter and Ward's triangle of the right side. Vertebral deformity was established in 30% of RA patient group and 7.1% of control group and this was statistically significant. In the statistical analysis, no statistically significant difference was found between BMD measurements of RA and control groups. Patients with RA were divided into two subgroups with regard to using corticosteroids (CS) or not. Vertebral deformity was 32.4% in the subgroup using CS and 24.1% in the subgroup not using CS, and the difference was not statistically significant. There was a correlation between number of deformed joint and age and vertebral deformity incidence. RA is a risk factor on its own for the development of osteoporosis and vertebral deformity and this risk increases by age, excess number of deformed joints and severe course of disease. We think that precautions should be taken immediately to suppress the disease activity as well as to protect the quality and density of bone and to prevent the development of vertebral deformity and fracture while planning the treatment of patients with RA.
本研究旨在调查类风湿关节炎(RA)女性患者中因骨质疏松而出现的椎体畸形与骨密度(BMD)及疾病活动参数之间的关联。在该研究中,招募了100名诊断为RA的女性患者和56名健康受试者。进行了红细胞沉降率(ESR)、C反应蛋白(CRP)和类风湿因子(RF)检测,并记录了肿胀和压痛关节的数量、疼痛程度及健康评估问卷(HAQ),以评估疾病活动情况。对所有患者进行胸部和腰骶部的前后位及侧位X线检查以进行影像学检查,并评估椎体畸形情况。对患者的腰椎L1 - 4椎体以及右侧全髋、股骨颈、大转子和沃德三角区进行骨密度测量。RA患者组中30%出现椎体畸形,对照组中为7.1%,差异具有统计学意义。在统计分析中,RA组和对照组的骨密度测量结果之间未发现统计学上的显著差异。根据是否使用皮质类固醇(CS),将RA患者分为两个亚组。使用CS的亚组中椎体畸形率为32.4%,未使用CS的亚组中为24.1%,差异无统计学意义。畸形关节数量与年龄及椎体畸形发生率之间存在相关性。RA本身就是骨质疏松和椎体畸形发生的一个危险因素,且随着年龄增长、畸形关节数量过多及疾病病程严重,这种风险会增加。我们认为,在规划RA患者的治疗时,应立即采取措施抑制疾病活动,同时保护骨骼质量和密度,防止椎体畸形和骨折的发生。